Therefore, it is essential to closely examine the functional similarities and heterogeneity of the IFN-γ/STAT1 pathway in gastrointestinal tumors when developing targeted therapeutic options focused on relevant downstream factors. Here, STAT1 is linked to digestive system neoplasm.